MedTrace Logo

Risk of Hypoglycemia in Type 2 Diabetes

NCT00734669 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2016-10-26

No results posted yet for this study

Summary

The aim of this study is to establish the risk and frequency of non-symptomatic hypoglycemia in type 2 diabetes under previous therapy with glibenclamide. Participants will be monitored via a continuous glucose monitoring system in a standardized clinical setting during day and night time, implementing meals and exercise of moderate intensity performed in the postprandial state.

Conditions

Interventions

DRUG

Glibenclamide

Taking a single dose of 3.5 mg glibenclamide

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2016-01-31
Completion
2016-10-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00734669 on ClinicalTrials.gov